3.4. Differences in Gut Microbiota Associated with Clinical Outcomes and Predicted Functional Pathways
After the intervention, regardless of the treatment modality, a distinct difference in overall gut microbiome composition was noted between the participants who reached the HbA1c target goal and those who did not (PERMANOVA; The group difference for the changes in the functional composition estimated by PICRUSt after the 24-week treatment in the two groups is shown in 